KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $37,000 | -89.2% | 14,038 | -78.4% | 0.00% | -100.0% |
Q2 2021 | $344,000 | +19.4% | 65,036 | +52.3% | 0.00% | 0.0% |
Q1 2021 | $288,000 | +54.8% | 42,700 | +55.5% | 0.00% | +100.0% |
Q4 2020 | $186,000 | -81.9% | 27,463 | -71.9% | 0.00% | -85.7% |
Q2 2020 | $1,027,000 | – | 97,729 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |